微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.97% | 9.71% | 143.63% | 27/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.04% | 7.37% | -76.2% | 37/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 8.57% | -2.06% | 11.01% | 26/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 7.72% | 9.97% | 70.42% | 25/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.53% | 8.63% | 138.42% | 31/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.9% | 1.6% | -78.29% | 50/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.75% | -12.94% | 24.64% | 38/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 7.02% | -4.49% | 68.35% | 44/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.17% | -7.74% | 122.99% | 47/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.87% | -24.29% | -81.39% | 53/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 10.05% | -44.63% | 36.73% | 33/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 7.35% | -45.23% | 62.61% | 45/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 4.52% | -43.99% | 83% | 52/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.47% | -31.01% | -86.39% | 51/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 18.15% | 39.08% | 35.25% | 31/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 13.42% | 27.08% | 66.29% | 37/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 8.07% | 36.78% | 125.42% | 43/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.58% | 12.23% | -72.57% | 42/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.05% | 23.58% | 23.58% | 66/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 10.56% | 15.54% | 78.98% | 57/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.9% | 44.25% | 84.95% | 74/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.19% | 145.38% | -69.79% | 53/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.56% | -30.25% | 15.54% | 86/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9.14% | -20.1% | 123.47% | 53/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.09% | -24.95% | 214.62% | 80/141 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 1.3% | -43.72% | -91.41% | 54/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 15.14% | -4.54% | 32.34% | 55/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 11.44% | 15.09% | 109.91% | 25/141 | 10.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2019-06-30 | 5.45% | 17.2% | 135.93% | 39/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.31% | 126.47% | -85.44% | 28/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 15.86% | 35.44% | 59.56% | 49/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.94% | 22.41% | 113.76% | 23/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.65% | -10.23% | 355.88% | 30/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.02% | -49.5% | -91.29% | 42/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 11.71% | 1.04% | 44.21% | 58/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 8.12% | 6.7% | 56.76% | 26/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 5.18% | 23.92% | 156.44% | 32/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.02% | 83.64% | -82.57% | 26/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 11.59% | 7.81% | 52.3% | 50/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 7.61% | 32.58% | 82.06% | 19/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.18% | 106.93% | 280% | 32/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.1% | -12.7% | -89.77% | 27/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |